HS-20118

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HS-20118, covering 2025-06-24 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118 [Phase 1]